2179 — Jiangsu Recbio Technology Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$2.53bn
- HK$2.86bn
- CNY12.73m
Annual cashflow statement for Jiangsu Recbio Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -658 | -736 | -572 | -562 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 181 | -87.8 | -4.16 | 44.4 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -18.7 | 203 | -125 | -28.2 | — |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -473 | -580 | -638 | -465 | — |
| Capital Expenditures | -238 | -308 | -224 | -172 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 307 | -69.9 | 234 | -107 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 68.7 | -378 | 9.42 | -279 | — |
| Financing Cash Flow Items | 20.8 | -2.84 | -10.4 | -14.7 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,229 | 839 | 275 | 218 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 817 | -3.47 | -334 | -516 | — |